Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
0.6984
+0.0544 (8.45%)
NASDAQ · Last Trade: Jul 15th, 1:25 AM EDT
Detailed Quote
Previous Close
0.6440
Open
0.7800
Bid
0.6100
Ask
0.6200
Day's Range
0.5600 - 0.8659
52 Week Range
0.4619 - 4.190
Volume
62,178,226
Market Cap
17.63M
PE Ratio (TTM)
-0.7055
EPS (TTM)
-1.0
Dividend & Yield
N/A (N/A)
1 Month Average Volume
3,585,307
Chart
About Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
Rani Therapeutics Holdings Inc. is a biopharmaceutical company focused on developing innovative oral therapies for the delivery of biologics, such as peptides and proteins, which traditionally require injection for administration. The company’s proprietary RaniPill platform utilizes a novel approach to encapsulate and deliver these treatments orally, aiming to enhance patient compliance and accessibility in the administration of complex medications. By combining advanced engineering with pharmaceutical expertise, Rani Therapeutics is exploring solutions that could revolutionize the landscape of therapeutic delivery, making it more patient-friendly. Read More
Power Metallic Mines Inc. (TSXV: PNPN | OTCQB: PNPNF) successfully closed of its strategic land acquisition from Li-FT Power Ltd. (TSXV: LIFT | OTCQX: LIFFF) adding a massive 313 mineral claims totaling 167 km² to its already dominant position in the polymetallic-rich Nisk region of Quebec.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Rani Therapeutics shares are trading lower by 23% Tuesday afternoon. The company announced a $10 million direct offering of 3 million shares at $3 per share.
